These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35884602)

  • 1. [68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time?
    Tabacchi E; Fortunati E; Argalia G; Zanoni L; Calabrò D; Telo S; Campana D; Lamberti G; Ricci C; Casadei R; Fanti S; Ambrosini V
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients.
    Bonazzi N; Fortunati E; Zanoni L; Argalia G; Calabrò D; Tabacchi E; Allegri V; Campana D; Andrini E; Lamberti G; Di Franco M; Casadei R; Ricci C; Mosconi C; Fanti S; Ambrosini V
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of increased 68Ga-DOTANOC uptake in the pancreatic head in a large series of extrapancreatic NET patients studied with sequential PET/CT.
    Castellucci P; Pou Ucha J; Fuccio C; Rubello D; Ambrosini V; Montini GC; Pettinato V; Malizia C; Lodi F; Fanti S
    J Nucl Med; 2011 Jun; 52(6):886-90. PubMed ID: 21571796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-Head Comparison of SSTR Antagonist [
    Viswanathan R; Ballal S; Yadav MP; Roesch F; Sheokand P; Satapathy S; Tripathi M; Agarwal S; Moon ES; Bal C
    Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
    Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
    J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.
    Berzaczy D; Giraudo C; Haug AR; Raderer M; Senn D; Karanikas G; Weber M; Mayerhoefer ME
    Clin Nucl Med; 2017 Sep; 42(9):669-674. PubMed ID: 28682844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma.
    Sharma P; Arora S; Karunanithi S; Khadgawat R; Durgapal P; Sharma R; Kandasamy D; Bal C; Kumar R
    Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):69-76. PubMed ID: 24740163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.
    Christiansen CD; Petersen H; Nielsen AL; Detlefsen S; Brusgaard K; Rasmussen L; Melikyan M; Ekström K; Globa E; Rasmussen AH; Hovendal C; Christesen HT
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):250-261. PubMed ID: 29116340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ga-68 DOTANOC PET/CT imaging in detection of primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India.
    Pruthi A; Pankaj P; Verma R; Jain A; Belho ES; Mahajan H
    J Gastrointest Oncol; 2016 Jun; 7(3):449-61. PubMed ID: 27284479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental 68Ga-DOTATATE uptake in the pancreatic head: A case report and a unique opportunity to improve clinical care.
    Lakhotia R; Jhawar S; Malayeri AA; Millo C; Del Rivero J; Ahlman MA
    Medicine (Baltimore); 2020 May; 99(22):e20197. PubMed ID: 32481385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors.
    Ambrosini V; Campana D; Bodei L; Nanni C; Castellucci P; Allegri V; Montini GC; Tomassetti P; Paganelli G; Fanti S
    J Nucl Med; 2010 May; 51(5):669-73. PubMed ID: 20395323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of renal uptake of 68Ga-DOTANOC PET/CT and estimated glomerular filtration rate before and after peptide receptor radionuclide therapy in patients with metastatic neuroendocrine tumours.
    Kaewput C; Vinjamuri S
    Nucl Med Commun; 2016 Dec; 37(12):1325-1332. PubMed ID: 27612032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic values of
    Kumar R; Vankadari K; Mittal BR; Bansal D; Trehan A; Sahu JK; Sankhyan N
    Eur Radiol; 2021 Jul; 31(7):4587-4594. PubMed ID: 33409780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT.
    Majala S; Seppänen H; Kemppainen J; Sundström J; Schalin-Jäntti C; Gullichsen R; Schildt J; Mustonen H; Vesterinen T; Arola J; Kauhanen S
    EJNMMI Res; 2019 Dec; 9(1):116. PubMed ID: 31872324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β1600 Q.Clear Digital Reconstruction of [
    Di Franco M; Fortunati E; Zanoni L; Bonazzi N; Mosconi C; Malizia C; Civollani S; Campana D; Andrini E; Lamberti G; Allegri V; Fanti S; Ambrosini V
    J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999406
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors.
    Zhou Z; Wang Z; Zhang B; Wu Y; Li G; Wang Z
    Front Endocrinol (Lausanne); 2021; 12():727327. PubMed ID: 34539577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Accessory Spleen Is an Important Pitfall of 68Ga-DOTANOC PET/CT in the Workup for Pancreatic Neuroendocrine Neoplasm.
    Rufini V; Inzani F; Stefanelli A; Castaldi P; Perotti G; Cinquino A; Indovina L; Rindi G
    Pancreas; 2017 Feb; 46(2):157-163. PubMed ID: 27846139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
    Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
    Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor.
    Sharma P; Naswa N; Kc SS; Alvarado LA; Dwivedi AK; Yadav Y; Kumar R; Ammini AC; Bal C
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2194-202. PubMed ID: 25030618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.